Pseudolymphomatous drug hypersensitivity syndrome (Q85599): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Forma incomum de reação a drogas caracterizada por pápulas eritematosas, nódulos e placas infiltradas, que surgem usualmente dentro de duas a sete semanas após o início do medicamento causador. Esta reação pode ser difícil de distinguir, tanto clínica quanto patologicamente, de um linfoma verdadeiro. Um grande número de drogas foi implicado, mas anticonvulsivantes, incluindo fenitoína e carbamazepina, são causas bem conhecidas. Essa condição pode demorar meses para se resolver após a interrupção do medicamento causador. | |||||||||||||||
| description / en | description / en | ||||||||||||||
An uncommon drug reaction characterised by an eruption of erythematous papules, nodules and infiltrated plaques arising usually within two to seven weeks of commencing the provoking drug. This reaction can be difficult to distinguish both clinically and histopathologically from a true lymphoma. A large number of drugs have been implicated but anticonvulsants including phenytoin and carbamazepine are well recognised causes. The condition may take months to resolve on withdrawal of the offending drug. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1697708659 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_1697708659 | |||||||||||||||
| Property / CURIE: CID11:ID_1697708659 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_1697708659 | |||||||||||||||
| Property / Canary Token: dki-india-ID_1697708659 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 10:57, 15 August 2026
An uncommon drug reaction characterised by an eruption of erythematous papules, nodules and infiltrated plaques arising usually within two to seven weeks of commencing the provoking drug. This reaction can be difficult to distinguish both clinically and histopathologically from a true lymphoma. A large number of drugs have been implicated but anticonvulsants including phenytoin and carbamazepine are well recognised causes. The condition may take months to resolve on withdrawal of the offending drug.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1697708659 |
||
| English | Pseudolymphomatous drug hypersensitivity syndrome |
An uncommon drug reaction characterised by an eruption of erythematous papules, nodules and infiltrated plaques arising usually within two to seven weeks of commencing the provoking drug. This reaction can be difficult to distinguish both clinically and histopathologically from a true lymphoma. A large number of drugs have been implicated but anticonvulsants including phenytoin and carbamazepine are well recognised causes. The condition may take months to resolve on withdrawal of the offending drug. |
Statements
CID11:ID_1697708659
0 references
dki-india-ID_1697708659
0 references
Concluído
0 references
13 August 2026
0 references
